Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Vis graf over relationer

Expertise

Breast cancer; biomarker research

Primære forskningsområder

Breast cancer; triple negative breast cancer; neoadjuvant therapy; immunotherapy

Aktuel forskning

Principal Investigator and national coordinator for the Keynote 173 study. A Phase 1b study evaluating neoadjuvant chemotherapy and immunotherapy for estrogen receptor and HER2 normal breast cancer (Rigshospitalet)

Mulige interessekonflikter

None

ID: 42244029